Stock 2R3 REATA PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Reata Pharmaceuticals, Inc. Börse Stuttgart

Equities

2R3

US75615P1030

Biotechnology & Medical Research

Delayed Börse Stuttgart
Other stock markets
 		5-day change 1st Jan Change
- EUR -.--% Intraday chart for Reata Pharmaceuticals, Inc. +0.63% +373.53%
2023 Reata Pharmaceuticals, Inc. Announces Management Changes CI
2023 Biogen Closes Reata Pharmaceuticals Acquisition MT

Income Statement Evolution (Annual data)

Fiscal Period:
Estimates

Balance Sheet Analysis

Fiscal Period:
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Bio Therapeutic Drugs

1st Jan change Capi.
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+11.60% 106B
BIONTECH SE Stock BioNTech SE
-4.68% 24.28B
ARGENX SE Stock argenx SE
-0.82% 21.96B
GENMAB A/S Stock Genmab A/S
-10.12% 18.16B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-42.12% 16.37B
BEIGENE, LTD. Stock BeiGene, Ltd.
-17.47% 15.56B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+2.77% 13.63B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+34.58% 12.27B
INSMED INCORPORATED Stock Insmed Incorporated
+77.64% 8.87B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. RETA Stock
  4. 2R3 Stock
  5. Financials Reata Pharmaceuticals, Inc.